The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.
Kalden
J R
JR
Department of Internal Medicine III, University Erlangen-Nuremberg, Erlangen, Germany.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D000069285:Infliximab; D012216:Rheumatic Diseases / Q000188:drug therapy*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000378:metabolism
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab